Richard G. Harris, MD, FACS

Harris is a urologic oncologist with UroPartners LLC in Chicago, Illinois.

Articles by Richard G. Harris, MD, FACS

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

ByRichard G. Harris, MD, FACS,E. David Crawford, MD,Brian Myre, MD

July 22nd 2022

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.

Latest Updated Articles

Letter: Declassifying Gleason 6 as a cancer would do more harm than good
Published: July 22nd 2022 | Updated:

Richard G. Harris, MD, FACS

Articles by Richard G. Harris, MD, FACS

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

Latest Updated Articles

Trending on Urology Times

FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures

Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC

Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study

Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer

BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC